retinopathy semaglutide GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know Semaglutide ameliorates retinal vascular permeability

Tirzepatide takes this concept even further

Results of the study: Type 2 diabetes group: Out of 710 patients, 194 were on semaglutide, and 516 were taking non-GLP-1 RA medications

Note: Ozempic , Mounjaro , Victoza , and metformin are not FDA-approved to treat obesity or for weight loss

The longer the gap in treatment, the more likely patients are to experience side effects when resuming the medication

Timeline Verification: One-time use of Ozempic may not be enough to establish eligibility

Enter Noom GLP-1 , a suite of programs from the digital health pioneer Noom that pairs these powerhouse meds with proven behavioral science